Back to search

Article

The Bcl-2 silencing with an Antisense Oligonucleotide: Increase early Apoptosis

2021-10-12

Abstract excerpt

<title>Abstract</title> <p>Background Breast cancer is a heterogenic disease and hormone dependence. Estrogen receptor is positive in more than seventy percent of breast cancer patients. Tamoxifen is an estrogen receptor (ER) antagonist and used as the first line of treatment. Drug resistance is a main reason in failure of cancer treatment and progression of the disease. Combination drug therapy is a method to t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c43a1a03-3b26-58c1-b3fd-eb974e42c3c2
DOI
10.21203/rs.3.rs-936588/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Bcl-2 silencing with an Antisense Oligonucleotide: Increase early ApoptosisDOI 10.21203/rs.3.rs-936588/v1
Select a neighboring publication to make it the new centre.